Trial Profile
An Open-Label, Non-Controlled Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs Etonogestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme Corp.; Organon; Schering-Plough
- 18 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jul 2009 New trial record